APA (7th ed.) Citation

SM, B., MW, L., TJ, C., LJ, G., JM, C., EC, H., . . . JN, K. (2023). Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophy. Science translational medicine, 15(677), eabo1815. https://doi.org/10.1126/scitranslmed.abo1815

Chicago Style (17th ed.) Citation

SM, Birch, et al. "Assessment of Systemic AAV-microdystrophin Gene Therapy in the GRMD Model of Duchenne Muscular Dystrophy." Science Translational Medicine 15, no. 677 (2023): eabo1815. https://doi.org/10.1126/scitranslmed.abo1815.

MLA (9th ed.) Citation

SM, Birch, et al. "Assessment of Systemic AAV-microdystrophin Gene Therapy in the GRMD Model of Duchenne Muscular Dystrophy." Science Translational Medicine, vol. 15, no. 677, 2023, p. eabo1815, https://doi.org/10.1126/scitranslmed.abo1815.